Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-09 Sale | 2025-10-10 6:38 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 20,811 | $12.62 | $262,635 | 216,162 (Direct) | View |
| 2025-09-29 Sale | 2025-10-01 5:02 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 7,624 | $10.03 | $76,469 | 236,973 (Direct) | View |
| 2025-09-10 Sale | 2025-09-12 4:30 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 7,734 | $10.02 | $77,495 | 244,597 (Direct) | View |
| 2025-05-12 Sale | 2025-05-14 4:49 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 20,602 | $7.9141 | $163,046 | 475,103 (Direct) | View |
| 2024-10-01 Sale | 2024-10-02 4:31 pm | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $10.11 | $101,052 | 11,286 (Direct) | View |
| 2024-09-03 Sale | 2024-09-04 8:20 pm | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $11.56 | $115,588 | 21,286 (Direct) | View |
| 2024-08-01 Sale | 2024-08-05 6:39 pm | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,100 | $13.51 | $136,454 | 32,686 (Direct) | View |
| 2024-08-01 Sale | 2024-08-05 6:39 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 100 | $15 | $1,500 | 170,037 (Direct) | View |
| 2024-07-29 Sale | 2024-07-30 5:01 pm | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 11,000 | $15.04 | $165,495 | 12,786 (Direct) | View |
| 2024-07-29 Sale | 2024-07-30 5:01 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 9,648 | $15.04 | $145,106 | 170,137 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-09-01 Tax Withholding | 2025-09-03 4:49 pm | N/A N/A | REGENXBIO Inc. | RGNX | Malzahn Craig Chief Technology Officer | 234 | $8.93 | 17,585 (Direct) | View |
| 2025-09-01 Tax Withholding | 2025-09-03 4:47 pm | N/A N/A | REGENXBIO Inc. | RGNX | Chan Mitchell Chief Financial Officer | 4,901 | $8.93 | 53,968 (Direct) | View |
| 2025-08-01 Tax Withholding | 2025-08-04 5:17 pm | N/A N/A | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Strategy & Legal Officer | 4,699 | $8.19 | 151,411 (Direct) | View |
| 2025-07-01 Tax Withholding | 2025-07-03 6:53 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 4,701 | $8.23 | 252,331 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:37 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | Fox Allan M. Director | 47,583 | $0 | 2,941,335 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:33 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | Zachary Jennifer Director | 47,583 | $0 | 61,879 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:33 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | Tasse Daniel Director | 47,583 | $0 | 58,869 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:33 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | STUMP DAVID C Director | 47,583 | $0 | 58,869 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:32 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 47,583 | $0 | 522,686 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:32 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | MIGAUSKY GEORGE V Director | 47,583 | $0 | 58,869 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:32 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | Glucksmann Alexandra Director | 47,583 | $0 | 58,869 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:31 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 47,583 | $0 | 58,869 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 4:31 pm | N/A 2035-05-30 | REGENXBIO Inc. | RGNX | Bennett Jean Director | 47,583 | $0 | 58,869 (Direct) | View |
| 2025-05-12 Exercise | 2025-05-14 4:49 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 20,602 | $0 | 475,103 (Direct) | View |
| 2025-05-12 Exercise | 2025-05-14 4:49 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 20,602 | $3.76 | 475,103 (Direct) | View |
| 2025-02-01 Tax Withholding | 2025-04-04 5:17 pm | N/A N/A | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer | 4,700 | $8.07 | 156,110 (Direct) | View |
| 2025-02-01 Tax Withholding | 2025-04-04 5:17 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 5,263 | $8.07 | 210,717 (Direct) | View |
| 2025-02-01 Tax Withholding | 2025-04-04 5:16 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 5,452 | $8.07 | 226,348 (Direct) | View |
| 2025-03-27 Exercise | 2025-03-31 5:05 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 30,752 | $0 | 495,705 (Direct) | View |
| 2025-03-27 Exercise | 2025-03-31 5:05 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 30,752 | $3.76 | 495,705 (Direct) | View |
Ownership | 2025-03-24 7:02 pm | N/A N/A | REGENXBIO Inc. | RGNX | Malzahn Craig Chief Technology Officer | 0 | $0 | 133,249 (Direct) | View |
| 2025-01-02 Option Award(A) | 2025-01-14 5:19 pm | N/A 2035-01-02 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 478,606 | $0 | 478,606 (Direct) | View |
| 2025-01-02 Tax Withholding | 2025-01-06 4:59 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 13,891 | $7.73 | 319,678 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:59 pm | N/A 2035-01-02 | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 167,991 | $0 | 319,678 (Direct) | View |
| 2025-01-02 Tax Withholding | 2025-01-06 4:59 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 12,630 | $7.73 | 327,521 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:59 pm | N/A 2035-01-02 | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 155,068 | $0 | 327,521 (Direct) | View |
| 2025-01-02 Tax Withholding | 2025-01-06 4:59 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 11,917 | $7.73 | 733,638 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:59 pm | N/A 2035-01-02 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 575,518 | $0 | 733,638 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:59 pm | N/A 2035-01-02 | REGENXBIO Inc. | RGNX | Chan Mitchell Chief Financial Officer | 62,547 | $0 | 62,547 (Direct) | View |
| 2025-01-02 Tax Withholding | 2025-01-06 4:59 pm | N/A N/A | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer | 11,395 | $7.73 | 384,160 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:59 pm | N/A 2035-01-02 | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer | 223,350 | $0 | 384,160 (Direct) | View |
| 2024-10-01 Exercise | 2024-10-02 4:31 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $0 | 11,286 (Direct) | View |
| 2024-10-01 Exercise | 2024-10-02 4:31 pm | N/A N/A | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $3.76 | 11,286 (Direct) | View |
| 2024-09-16 Option Award | 2024-09-18 5:04 pm | N/A 2034-09-16 | REGENXBIO Inc. | RGNX | Chan Mitchell Chief Financial Officer | 348,231 | $0 | 348,231 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-04 8:20 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $0 | 21,286 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-04 8:20 pm | N/A N/A | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $3.76 | 21,286 (Direct) | View |
| 2024-08-08 Exercise | 2024-08-12 4:58 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 36,316 | $0.85 | 444,351 (Direct) | View |
| 2024-08-08 Exercise | 2024-08-12 4:58 pm | N/A 2024-09-24 | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 36,316 | $0 | 444,351 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 6:41 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 58,386 | $0 | 165,578 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 6:39 pm | N/A N/A | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer | 56,446 | $0 | 172,205 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-05 6:39 pm | N/A N/A | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 100 | $12.74 | 32,686 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-05 6:39 pm | N/A 2026-06-01 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,100 | $0 | 32,686 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-05 6:39 pm | N/A N/A | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $3.76 | 32,686 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-05 6:38 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 1,363 | $9.945 | 185,083 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 6:38 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 58,867 | $0 | 185,083 (Direct) | View |
| 2024-07-29 Exercise | 2024-07-30 5:01 pm | N/A N/A | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 11,000 | $12.74 | 12,786 (Direct) | View |
| 2024-07-29 Exercise | 2024-07-30 5:01 pm | N/A 2026-06-01 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 11,000 | $0 | 12,786 (Direct) | View |